临床表现 临床表现
Caitlin S Walker1, Garance Barnoin2, Mitchell Bennett2
1Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, QC, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
患阿尔茨海默氏症 (AD) 风险较高的老年人对亲社会奖励的动机更大. 特定的OPRL1基因变异会影响冷漠程度,这表明基因与衰老的动机有联系.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 心理学 心理学 心理学
背景情况:
- 漠不关心是早期阿尔茨海默病 (AD) 的常见症状,其特征是动机减少.
- 老年人往往优先考虑亲社会行为,这种倾向可能会在AD早期持续存在.
- 亲社会奖励在激励努力中的作用及其与高危老年人冷漠的关系仍然不清楚.
研究的目的:
- 调查亲社会奖励是否比自我服务奖励更有效,以激励老年人患AD风险的努力.
- 检查OPRL1基因中的遗传变异如何调节亲社会取向和冷漠之间的关系.
主要方法:
- 52名患有阿尔茨海默症风险的老年人完成了一项计算机化任务,评估了对亲社会 (捐款) 和自我服务 (金钱) 奖励的努力.
- 用各种函数分析了奖励-努力折扣曲线,以确定最合适的曲线.
- 回归模型检查了亲社会取向和冷漠之间的关联,其中OPRL1单核酸多态 (SNP) rs6010718和rs6010719作为调节者.
主要成果:
- 西格功能最好地描述了奖励-努力折扣曲线.
- 与自我服务的激励相比,参与者对亲社会的激励付出了更多的努力,需要的奖励也更少.
- OPRL1 rs6010718次要等位基因携带者表现出与亲社会努力相关的冷漠性减少,而rs6010719次要等位基因携带者表现出更高的冷漠性.
结论:
- 面临阿尔茨海默病风险的老年人更愿意为亲社会奖励而付出努力,与自我服务相比,需要更小的激励.
- 在OPRL1 SNPs中的遗传变异影响了亲社会取向和冷漠之间的相互作用.
- 特定的OPRL1基因型可能与衰老期间亲社会努力的背景下,冷漠行为减少有关.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


